EBQ:Mortality in Multicenter Critical Care Trials: An Analysis of Interventions with a Significant Effect: Difference between revisions

No edit summary
No edit summary
Line 38: Line 38:
# Growth hormone treatment  
# Growth hormone treatment  
# Supernormal systemic oxygen delivery
# Supernormal systemic oxygen delivery
# Intensive insulin therapy
# Intensive insulin therapy (target blood glucose of 81-180)


==Major Points==  
==Major Points==  

Revision as of 19:39, 18 January 2016

Incomplete Journal Club Article
Landoni G et al. "Mortality in Multicenter Critical Care Trials: An Analysis of Interventions With a Significant Effect". Critical Care Medicine. 2015. 43(8):1559–1568.
PubMed Full text PDF

Clinical Question

What interventions have been shown in multicenter RCT's to affect mortality in adult critically ill patients?

Conclusion

Of all the interventions done in critical care, the authors of this study identified 15 total treatments that increased or decreased mortality as documented in a randomized, controlled trail.

The following interventions decreased mortality:

  1. Noninvasive Ventilation
  2. Mild hypothermia after cardiac arrest (32-34C)
  3. Prone Positioning in ARDS
  4. Low tidal volume ventilation in ARDS
  5. TXA in patients with or at high risk of traumatic hemorrhagic shock
  6. Daily interruption of sedatives in critically ill patients
  7. Albumin in cirrhotic patients with SBP

The following interventions increased mortality:

  1. Diaspirin cross linked hemoglobin in traumatic hemorrhagic shock
  2. Starch in septic shock
  3. Ventilation with high frequency oscillation
  4. IV Salbutamol in ARDS
  5. Glutamine supplementation
  6. Growth hormone treatment
  7. Supernormal systemic oxygen delivery
  8. Intensive insulin therapy (target blood glucose of 81-180)

Major Points

Study Design

  • Systematic search & review of the literature involving multi center RCT's of interventions influencing mortality in critically ill patients.
  • Search via MEDLINE, Pubmed Scopus, Embase
  • Consensus conference of experts participated in an in person meeting to evaluate the methodological robustness of all interventions studies to determine if individual papers should be included in the review

Article Selection

The authors of this review searched MEDLINE/PubMed, Scopus and Embase for trials in peer reviewed journals with the following inclusion and exclusion criteria:

Inclusion Criteria

In order to be included in the review, articles need to see the following 4 criteria:

  1. Publication in a peer reviewed journal
  2. mRCT design (m = any trial involving more than one hospital)
  3. Dealing with nonsurgical interventions in adult critically ill patients
  4. Statistical significant reduction or increase in unadjusted landmark mortality

[For the purpose of this review, critically ill patients referred to those patients with acute failure of at least one organ and/or need for intensive/emergent treatment, regardless of where they were treated (ICU, ED, etc.)]

Exclusion Criteria

All studies were excluded that fulfilled any of the following:

  1. Quasi randomized or non randomized methods
  2. Dealt with surgical interventions
  3. Involved pediatric population
  4. Dealt with only the perioperative period
  5. Were performed out of the hospital
  6. Showed mortality effect only in a subgroup or after adjusted analysis
  7. Had low (<50%) agreement levels among surveyed clinicians

Results

A total of 15 interventions were identified from the selected 24 total studies that were included in this paper.

Interventions That Decreased Mortality

Treatment Absolute Mortality Reduction Relative Mortality Reduction NNT
Albumin 0.191 0.668 5
Sedation Vacation 0.134 0.232 7
Mild Hypothermia 0.142 0.258 7
NIV 0.193 0.675 5
NIV 0.2 0.714 5
NIV 0.101 0.598 10
NIV 0.214 0.548 5
NIV 0.142 0.871 8
NIV 0.12 0.828 7
NIV 0.197 0.64 5
NIV 0.122 0.836 8
Prone Position 0.168 0.512 6
Protective Vent 0.329 0.465 3
Protective Vent 0.088 0.222 11
Protective Vent 0.238 0.441 4
TXA 0.015 0.094 68

Interventions That Increased Mortality

Characteristics of Trials Selected

Criticisms & Further Discussion

See Also

Funding

Funded in part by departmental funds from the Department of Anesthesia & Intensive Care, IRCCSS San Raffaele Scientific Institute (Milan, Italy)

References